Results 201 to 210 of about 55,815 (216)

Sorafenib

Reactions Weekly, 2012
openaire   +1 more source

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma

Acta Pharmacologica Sinica, 2020
Guo-Dong Lu, Jing Zhou, Jing-Huan Deng   +2 more
exaly  

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

Hepatology Research, 2013
Angela Gauthier, Mitchell Ho
exaly  

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

Annals of Oncology, 2016
Tosiya Sato, S Nakamori, J Furuse
exaly  

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2017
Yi-Hsiang Huang, Gianluca Masi, Shukui Qin   +2 more
exaly  

Binding interaction of sorafenib with bovine serum albumin: Spectroscopic methodologies and molecular docking

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2015
Jie-Hua Shi
exaly  

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

International Journal of Cancer, 2012
Antoine Galmiche
exaly  

Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib

Journal of Hepatology, 2018
Kwan Man, Man Tong, Elly Ngan
exaly  

Nanoparticles for controlled release of Sorafenib and Sorafenib derivatives

2018
PITARRESI GIOVANNA, CERVELLO MELCHIORRE, AZZOLINA ANTONINA, PULEIO ROBERTO, LORIA GUIDO RUGGERO, PULEO STEFANO, GIAMMONA GAETANO   +6 more
openaire   +3 more sources

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

Annals of Oncology, 2013
, Roberto Labianca, Lorenza Rimassa
exaly